Search ACONW
Aclarion, Inc.
Nasdaq, Nasdaq · CIK 1635077
Last close0.03
Daily change+0.00 (17.65%)
10 Years gain-13.04%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ACONW · STANDARD
SIC 8071 · Services-Medical Laboratories · Fiscal year end 1231
Fundamental
51.2Momentum
0.0Acceleration
0.0Confidence
73.0Annual Revenue5
Quarterly Revenue17
Annual CFO5
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth15.4 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics5.7 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 86.2465 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 1631.9427 percentage points.
Heavy share dilution · HIGHDiluted share count increased 1022.4392%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
ROIC declining · MEDIUMROIC declined by 34.9713 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM55.29%OK
Revenue CAGR 3Y7.8%OK
Gross Margin25.5%OK
Operating Margin-11,173.91%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-90.54%OK
Incremental Operating Margin 3Y-17,748.25%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y1,022.44%OK
SBC / Revenue179.55%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $75,730.00 | $6,828.00 | -$7.05M | -$7.16M | -$7.19M | 9.02% | -9,312.55% | -9,488.62% | -834.21% | 532,036 |
| 2025 FY Dec 31, 2024 | $45,724.00 | -$38,934.00 | -$5.51M | -$5.27M | -$5.28M | -85.15% | -12,057.23% | -11,540.38% | n/a | 943 |
| 2024 FY Dec 31, 2023 | $75,404.00 | -$324.00 | -$4.88M | -$3.65M | -$3.65M | -0.43% | -6,466.48% | -4,836.54% | n/a | 62 |
| 2023 FY Dec 31, 2022 | $60,444.00 | -$4,854.00 | -$5.56M | -$4.95M | n/a | -8.03% | -9,201.19% | n/a | n/a | 381,598 |
| 2022 FY Dec 31, 2021 | $60,292.00 | -$8,883.00 | -$2.95M | -$2.40M | n/a | -14.73% | -4,897.89% | n/a | n/a | 905,685 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $84,609.00 | sum latest 4 fiscal quarters Revenue | OK | 0001683168-26-006026, 0001683168-25-008169 |
| Revenue Growth TTM | 55.29% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001683168-26-006026, 0001683168-25-008169 |
| Revenue CAGR 3Y | 7.8% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001683168-26-001986 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001683168-26-001986 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001683168-26-001986 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001683168-26-006026, 0001683168-25-008169 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 25.5% | Gross Profit / Revenue | OK | 0001683168-26-006026, 0001683168-25-008169 |
| Operating Margin | -11,173.91% | Operating Income / Revenue | OK | 0001683168-26-006026, 0001683168-25-008169 |
| ROIC | -90.54% | NOPAT / Average Invested Capital | OK | 0001683168-26-006026, 0001683168-25-008169 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001683168-26-006026 |
| Current Ratio | 16.2x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 179.55% | SBC / Revenue | OK | 0001683168-26-006026, 0001683168-25-008169 |
| Revenue per Diluted Share | $0.03 | Revenue / Diluted Shares | OK | 0001683168-26-006026, 0001683168-25-008169 |